Insights On Partnering

  1. Consolidating Access Into A Single Platform: A Site CEO's Perspective 2/28/2025

    By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

  2. Scaling Outsourced Clinical Trial Services 6/16/2026

    Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.

  3. Why Your Bioanalysis Bottleneck Is Costing You More Than You Think 3/9/2026

    This piece explains why turnaround time is a strategic variable, where speed is truly achievable, and how automation reshapes the path from sample submission to decision‑ready data.

  4. Enhancing Clinical Trial Flexibility 9/1/2025

    Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.

  5. How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs 3/17/2025

    Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

  6. What Your Payment Structure Says About Your Trial 7/13/2026

    Payment models influence trial efficiency, cost control, and site satisfaction. Choosing between visit-based simplicity and procedure-based precision can significantly impact budget accuracy, data timeliness, and overall study performance.

  7. The Real Reason Sites Haven't Digitized 5/11/2026

    Reducing site burden doesn’t require major change. Streamlining one workflow can boost efficiency, support compliance, and free staff to focus on patients.

  8. The Triple Effect Of Community-Based Clinical Trials 6/24/2026

    Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.

  9. Critical Imaging Risks In GLP-1 And Neurology Studies 4/3/2025

    In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.

  10. How To Capture Growth In The Expanding Metabolic Drug Market 12/2/2025

    Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.